Patterson Matthew R Insider Trading
Get the latest insider transactions of Patterson Matthew R. Patterson Matthew R is Acting CEO & President in AMICUS THERAPEUTICS INC ($FOLD) and Chief Operating Officer in AMICUS THERAPEUTICS INC ($FOLD) and Chief Executive Officer in Audentes Therapeutics, Inc. ($BOLD) and President & CEO in Audentes Therapeutics, Inc. ($BOLD) and Director in Homology Medicines, Inc. ($FIXX) and Director in Vor Biopharma Inc. ($VOR) and Director in 5:01 Acquisition Corp. ($FVAM). Discover the current value of Patterson Matthew R shares.
Address: C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE CRANBURY 08512NJ
Patterson Matthew R is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS, INC. | Acting CEO & President, Chief Operating Officer | 106,547 | 641,412.94 |
| BOLD | Audentes Therapeutics, Inc. | Chief Executive Officer, President & CEO | 0 | 0.00 |
| FIXX | Homology Medicines, Inc. | Director | 0 | |
| FVAM | 5:01 Acquisition Corp. | Director | 0 | |
| VOR | Vor Biopharma Inc. | Director | 0 |
Insider Trading Transactions of Patterson Matthew R
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | FIXX | Homology Medicines, Inc. | Patterson Matthew R | Director | Option Exercise | 7.26 | 18,000 | 130,680 | 18,000 |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Patterson Matthew R | Director | Option Exercise | 18.00 | 16,900 | 304,200 | 16,900 |
| Oct 20 2020 | FVAM | 5:01 Acquisition Corp. | Patterson Matthew R | Director | Option Exercise | 0.00 | 30,000 | 0 | 30,000 |
| Oct 20 2020 | FVAM | 5:01 Acquisition Corp. | Patterson Matthew R | Director | Option Exercise | 0.00 | 30,000 | 0 | 30,000 |
| Jun 12 2020 | FIXX | Homology Medicines, Inc. | Patterson Matthew R | Director | Option Exercise | 16.32 | 18,000 | 293,760 | 18,000 |
| Jan 15 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 60.00 | 261,458 | 15,687,480 | 0 |
| Jan 15 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 60.00 | 171,814 | 10,308,840 | 0 |
| Jan 15 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 9.50 | 143,569 | 1,363,733 | 0 |
| Jan 15 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 15.26 | 188,334 | 2,873,977 | 0 |
| Jan 15 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 27.39 | 225,000 | 6,162,750 | 0 |
| Jan 15 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 24.74 | 177,450 | 4,390,113 | 0 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 0.00 | 12,500 | 0 | 98,920 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 64,751 | 50,506 | 163,671 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 2.19 | 74,297 | 162,710 | 237,968 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 9.50 | 11,824 | 112,328 | 249,792 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 15.26 | 11,666 | 178,023 | 261,458 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 64,751 | 50,506 | 0 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 2.19 | 74,297 | 162,710 | 0 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 9.50 | 11,824 | 112,328 | 143,569 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 15.26 | 11,666 | 178,023 | 188,334 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 0.00 | 12,500 | 0 | 98,920 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 64,751 | 50,506 | 163,671 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 2.19 | 74,297 | 162,710 | 237,968 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 9.50 | 11,824 | 112,328 | 249,792 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 15.26 | 11,666 | 178,023 | 261,458 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 64,751 | 50,506 | 0 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 2.19 | 74,297 | 162,710 | 0 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 9.50 | 11,824 | 112,328 | 143,569 |
| Jan 10 2020 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 15.26 | 11,666 | 178,023 | 188,334 |
| Dec 09 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 59.21 | 1,974 | 116,881 | 111,420 |
| Nov 12 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 9.50 | 14,426 | 137,047 | 127,820 |
| Nov 12 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 30.00 | 14,426 | 432,780 | 113,394 |
| Nov 12 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 9.50 | 14,426 | 137,047 | 155,393 |
| Sep 09 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 31.02 | 1,974 | 61,233 | 113,394 |
| Aug 14 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 9.50 | 20,000 | 190,000 | 135,368 |
| Aug 14 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 34.02 | 19,000 | 646,310 | 116,368 |
| Aug 14 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 34.53 | 1,000 | 34,525 | 115,368 |
| Aug 14 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 9.50 | 20,000 | 190,000 | 169,819 |
| Jun 10 2019 | FIXX | Homology Medicines, Inc. | Patterson Matthew R | Director | Option Exercise | 19.51 | 15,580 | 303,966 | 15,580 |
| Jun 07 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 37.31 | 3,332 | 124,317 | 115,368 |
| Jun 07 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 37.31 | 3,332 | 124,317 | 115,368 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 17,000 | 13,260 | 135,700 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 30.00 | 17,000 | 510,000 | 118,700 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 2.19 | 4,000 | 8,760 | 122,700 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 30.00 | 4,000 | 120,000 | 118,700 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 17,000 | 13,260 | 64,751 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 2.19 | 4,000 | 8,760 | 74,297 |
| Feb 08 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.00 | 63,700 | 0 | 118,700 |
| Feb 08 2019 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 24.74 | 177,450 | 4,390,113 | 177,450 |
| Dec 10 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 40,000 | 31,200 | 55,000 |
| Dec 10 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 40,000 | 31,200 | 31,702 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 2,144 | 1,672 | 17,144 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 39.14 | 2,144 | 83,905 | 15,000 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 5,330 | 4,157 | 20,330 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 38.04 | 5,330 | 202,732 | 15,000 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 5,448 | 4,249 | 20,448 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 38.58 | 5,448 | 210,162 | 15,000 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 8,078 | 6,301 | 23,078 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 37.70 | 8,078 | 304,573 | 15,000 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 21,000 | 16,380 | 71,702 |
| Sep 24 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 15,000 | 11,700 | 15,000 |
| Sep 24 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 15,000 | 11,700 | 92,702 |
| Sep 20 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 2.19 | 12,952 | 28,365 | 12,952 |
| Sep 20 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 40.00 | 12,952 | 518,080 | 0 |
| Sep 20 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 2.19 | 12,952 | 28,365 | 128,345 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 19,599 | 15,287 | 19,599 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 38.33 | 19,599 | 751,194 | 0 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 1,401 | 1,093 | 1,401 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 38.78 | 1,401 | 54,330 | 0 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 26,901 | 20,983 | 26,901 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 40.05 | 26,901 | 1,077,460 | 0 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Buy | 0.78 | 23,147 | 18,055 | 23,147 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Sell | 40.04 | 23,147 | 926,852 | 0 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 19,599 | 15,287 | 159,151 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 1,401 | 1,093 | 157,750 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 26,901 | 20,983 | 130,849 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | Chief Executive Offic ... | Option Exercise | 0.78 | 23,147 | 18,055 | 107,702 |
| May 23 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Buy | 0.78 | 13,600 | 10,608 | 13,600 |
| May 23 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 38.08 | 13,600 | 517,888 | 0 |
| May 23 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Buy | 0.78 | 6,700 | 5,226 | 6,700 |
| May 23 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 38.30 | 6,700 | 256,610 | 0 |
| May 23 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Option Exercise | 0.78 | 20,300 | 15,834 | 178,750 |
| Apr 04 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Buy | 0.78 | 700 | 546 | 700 |
| Apr 04 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 30.01 | 700 | 21,009 | 0 |
| Apr 04 2018 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Option Exercise | 0.78 | 700 | 546 | 199,050 |
| Mar 29 2018 | FIXX | Homology Medicines, Inc. | Patterson Matthew R | Director | Option Exercise | 16.00 | 8,360 | 133,760 | 8,360 |
| Nov 17 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Option Exercise | 27.39 | 225,000 | 6,162,750 | 225,000 |
| Oct 04 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Buy | 0.78 | 10,000 | 7,800 | 10,000 |
| Oct 04 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 27.92 | 10,000 | 279,217 | 0 |
| Oct 04 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 27.92 | 15,000 | 418,853 | 171,814 |
| Oct 04 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Option Exercise | 0.78 | 10,000 | 7,800 | 199,750 |
| Sep 19 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Buy | 0.78 | 1,542 | 1,203 | 1,542 |
| Sep 19 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 25.00 | 1,542 | 38,551 | 0 |
| Sep 19 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Buy | 0.78 | 8,458 | 6,597 | 8,458 |
| Sep 19 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 25.07 | 8,458 | 212,010 | 0 |
| Sep 19 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Option Exercise | 0.78 | 1,542 | 1,203 | 218,208 |
| Sep 19 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Option Exercise | 0.78 | 8,458 | 6,597 | 209,750 |
| Jul 14 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 20.00 | 2,850 | 57,007 | 198,964 |
| Jul 14 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Sell | 20.00 | 12,150 | 243,052 | 186,814 |
| Jan 27 2017 | BOLD | Audentes Therapeutics, In ... | Patterson Matthew R | President & CEO | Option Exercise | 15.26 | 200,000 | 3,052,000 | 200,000 |
| Apr 19 2011 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Acting CEO & Presiden ... | Buy | 0.00 | 50,000 | 0 | 106,547 |
| Jan 20 2011 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 5.96 | 50,000 | 298,000 | 50,000 |
| Jun 17 2010 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 2.81 | 30,000 | 84,300 | 30,000 |
| Nov 17 2009 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 4.16 | 80,000 | 332,800 | 80,000 |
| Feb 05 2009 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 10.36 | 54,000 | 559,440 | 54,000 |
| Dec 04 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Buy | 0.64 | 20,098 | 12,823 | 56,547 |
| Dec 04 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 0.64 | 20,098 | 12,823 | 0 |
| Nov 03 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.00 | 361 | 3,610 | 38,388 |
| Nov 03 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.00 | 1,939 | 19,390 | 36,449 |
| Oct 24 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.40 | 3,100 | 32,246 | 38,849 |
| Oct 24 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.10 | 100 | 1,010 | 38,749 |
| Oct 22 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.73 | 1,900 | 20,393 | 44,549 |
| Oct 22 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.51 | 100 | 1,151 | 44,449 |
| Oct 22 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.51 | 2,500 | 26,263 | 41,949 |
| Aug 21 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 13.54 | 2,000 | 27,070 | 46,449 |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 15.02 | 2,700 | 40,554 | 53,749 |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 16.04 | 800 | 12,834 | 52,949 |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 13.71 | 3,800 | 52,094 | 49,149 |
| Aug 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 14.50 | 700 | 10,149 | 48,449 |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.25 | 277 | 3,116 | 59,672 |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.26 | 123 | 1,385 | 59,549 |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.35 | 400 | 4,540 | 59,149 |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.50 | 200 | 2,300 | 58,949 |
| Jun 24 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.54 | 400 | 4,616 | 58,549 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.95 | 100 | 1,095 | 61,749 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.97 | 400 | 4,388 | 61,349 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.99 | 100 | 1,099 | 61,249 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.00 | 400 | 4,400 | 60,849 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.01 | 200 | 2,202 | 60,649 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.02 | 200 | 2,204 | 60,449 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.12 | 100 | 1,112 | 60,349 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.02 | 86 | 948 | 60,263 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.03 | 300 | 3,309 | 59,963 |
| Jun 20 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.11 | 14 | 156 | 59,949 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.12 | 200 | 2,224 | 66,249 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.13 | 400 | 4,452 | 65,849 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.15 | 100 | 1,115 | 65,749 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.16 | 200 | 2,232 | 65,549 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.17 | 400 | 4,468 | 65,149 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.18 | 500 | 5,590 | 64,649 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.19 | 857 | 9,590 | 63,792 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.20 | 500 | 5,600 | 63,292 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.21 | 1,043 | 11,692 | 62,249 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.22 | 400 | 4,488 | 61,849 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.23 | 200 | 2,246 | 61,649 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.25 | 100 | 1,125 | 61,549 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.00 | 390 | 4,290 | 61,159 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.01 | 100 | 1,101 | 61,059 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.03 | 100 | 1,103 | 60,959 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.05 | 500 | 5,525 | 60,459 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.06 | 100 | 1,106 | 60,359 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.07 | 100 | 1,107 | 60,259 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.08 | 10 | 111 | 60,249 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.15 | 300 | 3,345 | 59,949 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.16 | 100 | 1,116 | 59,849 |
| Jun 18 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 11.20 | 100 | 1,120 | 59,749 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.00 | 100 | 1,000 | 76,349 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.12 | 100 | 1,012 | 76,249 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.14 | 400 | 4,056 | 75,849 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.19 | 100 | 1,019 | 75,749 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.22 | 304 | 3,107 | 75,445 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.24 | 796 | 8,151 | 74,649 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.32 | 100 | 1,032 | 74,549 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.36 | 4 | 41 | 74,545 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.37 | 96 | 996 | 74,449 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.48 | 100 | 1,048 | 74,349 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.56 | 300 | 3,168 | 74,049 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.57 | 200 | 2,114 | 73,849 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.61 | 1,000 | 10,610 | 72,849 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.62 | 91 | 966 | 72,758 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.64 | 200 | 2,128 | 72,558 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.65 | 600 | 6,390 | 71,958 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.66 | 200 | 2,132 | 71,758 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.67 | 9 | 96 | 71,749 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.68 | 200 | 2,136 | 71,549 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.69 | 100 | 1,069 | 71,449 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.70 | 200 | 2,140 | 71,249 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.71 | 100 | 1,071 | 71,149 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.73 | 200 | 2,146 | 70,949 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.74 | 100 | 1,074 | 70,849 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.76 | 400 | 4,304 | 70,449 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.00 | 800 | 8,000 | 69,649 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.01 | 400 | 4,004 | 69,249 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.02 | 522 | 5,230 | 68,727 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.15 | 100 | 1,015 | 68,627 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.18 | 700 | 7,126 | 67,927 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.26 | 100 | 1,026 | 67,827 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.27 | 400 | 4,108 | 67,427 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.28 | 200 | 2,056 | 67,227 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.38 | 200 | 2,076 | 67,027 |
| Apr 16 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Sell | 10.00 | 578 | 5,780 | 66,449 |
| Feb 25 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Buy | 0.64 | 12,083 | 7,709 | 76,449 |
| Feb 25 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 0.64 | 12,083 | 7,709 | 20,098 |
| Feb 07 2008 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 10.21 | 45,000 | 459,450 | 45,000 |
| Aug 28 2007 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Buy | 0.64 | 32,366 | 20,650 | 64,366 |
| Aug 28 2007 | FOLD | AMICUS THERAPEUTICS INC | Patterson Matthew R | Chief Operating Offic ... | Option Exercise | 0.64 | 32,366 | 20,650 | 32,181 |